No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2216 |
4. Check minimum number of eventsNone |
2216 |
5. Include endpointsNone |
2216 |
6. Filter based on genotype QC (FinnGen only) |
978 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemia myeloides
Similar endpoints
↥List of similar endpoints to
Myeloid leukaemia
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 978 | 431 | 547 |
| Unadjusted period prevalence (%) | 0.21 | 0.15 | 0.25 |
| Median age at first event (years) | 66.40 | 62.40 | 69.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1051
- Matched controls
- 10510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW500
NOMESCO Finland
Blood transfusion
17.3
316.4
292
229
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
307.7
344
*
XW000
NOMESCO Finland
Bone marrow biopsy
60.2
307.7
588
217
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
307.7
341
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
140.4
307.7
817
255
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
307.7
665
*
L01XX05
ATC
hydroxycarbamide; oral
36.3
266.8
171
56
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
19.7
266.3
221
140
L03AA02
ATC
filgrastim; parenteral
19.2
261.6
220
143
127
Kela drug reimbursment
Transplant complication
35.7
257.9
166
55
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
103.0
245.4
127
14
M04AA01
ATC
allopurinol; systemic
7.8
237.5
472
990
A05AA02
ATC
ursodeoxycholic acid; oral
31.8
219.7
146
53
189
Kela drug reimbursment
Imatinib
582.1
199.7
192
*
A04AA01
ATC
ondansetron; systemic, rectal
8.5
192.8
299
470
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
65.4
191.7
106
18
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
64.2
178.6
99
17
L01XE01
ATC
[U] imatinib
615.6
163.7
158
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
162.8
152
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
54.8
141.9
81
16
L01EA01
ATC
imatinib; oral
481.6
131.0
128
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.2
127.0
339
877
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
357.1
126.3
125
*
R50.9
ICD-10 Finland
Fever, unspecified
5.0
124.7
363
1007
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
22.0
120.8
91
45
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
117.4
315
813
D70.89
ICD-10 Finland
Neutropenic splenomegaly
21.3
115.1
88
45
L01BB02
ATC
mercaptopurine; oral
25.7
114.7
81
34
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.6
109.1
197
353
316
Kela drug reimbursment
Imatinib
1139.2
107.3
103
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.1
105.8
175
286
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.5
103.3
84
49
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
27.7
102.0
70
27
J05AB11
ATC
valaciclovir; oral
4.5
100.6
315
909
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.2
99.8
98
81
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.6
98.1
176
312
399
Kela drug reimbursment
Venetoclax
58.0
97.4
55
10
212
Kela drug reimbursment
Gout
12.2
95.6
99
89
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
19.0
94.8
76
43
L04AD01
ATC
ciclosporin; systemic
14.9
92.1
84
61
1518, ,
Kela drug reimbursment
54.7
91.0
52
10
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.5
88.7
121
158
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.3
86.5
136
209
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
26.6
83.5
58
23
J01MA12
ATC
levofloxacin; systemic
3.6
81.4
369
1358
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
35.7
80.7
51
15
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
288.8
79.7
80
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
77.2
264
799
J02AC03
ATC
voriconazole; systemic
146.1
77.1
81
6
WW200
NOMESCO Finland
Immunization
9.2
73.6
93
110
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
265.0
73.4
74
*
L04AA01
ATC
[U] ciclosporin
15.7
69.5
61
41
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
66.4
63
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.2
66.0
120
213
121
Kela drug reimbursment
Severe hypofunction of sexual glands
10.5
65.5
74
75
152
Kela drug reimbursment
Nilotinib
+∞
65.3
62
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
62.1
59
*
Z51.5
ICD-10 Finland
Palliative care
3.9
61.4
212
638
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
21.3
59.5
45
22
B73
ICPC
Leukaemia
161.7
58.6
61
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
600.0
58.2
57
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
57.5
681
4111
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
577.6
56.1
55
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
16.4
54.9
47
30
J01MA14
ATC
moxifloxacin; systemic
3.9
54.8
187
556
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
53.6
51
*
L01XX28
ATC
[U] imatinib
+∞
50.4
48
*
150
Kela drug reimbursment
Dasatinib
+∞
49.4
47
*
B03XA02
ATC
darbepoetin alfa; parenteral
7.0
48.5
76
115
ZX112
NOMESCO Finland
Subcutaneous
7.2
48.4
74
109
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
46.2
44
*
L01XX52
ATC
venetoclax; oral
68.3
45.6
52
8
ZX120
NOMESCO Finland
Intravenous
3.5
44.4
174
563
J02AC04
ATC
posaconazole; systemic
234.8
44.3
45
*
TGC00
NOMESCO Finland
Bronchial lavation
6.2
44.1
78
134
C90.0
ICD-10 Finland
Multiple myeloma
9.9
43.6
51
54
L04AA06
ATC
mycophenolic acid; systemic
8.4
43.4
58
73
H02AB09
ATC
hydrocortisone; systemic
7.2
43.2
66
97
328
Kela drug reimbursment
Nilotinib
+∞
43.0
41
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
42.2
288
1277
L01XE06
ATC
[U] dasatinib
+∞
42.0
40
*
L01XE08
ATC
[U] nilotinib
+∞
40.9
39
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.8
40.0
47
50
L01EA03
ATC
nilotinib; oral
+∞
39.8
38
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
38.8
37
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
38.8
37
*
J05AB01
ATC
aciclovir; systemic
2.5
37.7
301
1432
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.7
37.6
91
207
L04AD02
ATC
tacrolimus; systemic
12.4
36.0
36
30
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.3
35.2
74
149
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
34.6
33
*
JN4AD
NOMESCO Finland
Body CT examination
2.8
33.6
200
818
N02AA05
ATC
oxycodone; systemic
2.4
33.5
299
1486
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
175.5
32.9
34
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.6
32.6
117
355
D45
ICD-10 Finland
Polycythaemia vera
9.8
32.5
38
40
B03XA01
ATC
erythropoietin; parenteral
9.8
31.6
37
39
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
54.7
31.5
37
7
L01EA02
ATC
dasatinib; oral
+∞
30.4
29
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
30.2
388
2228
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.9
29.3
91
250
JN6AD
NOMESCO Finland
CT of torso and neck
6.6
28.8
47
74
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
28.3
27
*
324
Kela drug reimbursment
Dasatinib
+∞
28.3
27
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
28.2
336
1864
A41.8
ICD-10 Finland
Other specified sepsis
5.5
27.5
54
102
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
27.4
176
743
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.3
27.4
47
78
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
31.0
27.4
36
12
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
27.2
26
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
99.4
26.8
29
*
WW409
NOMESCO Finland
Other aferesis
47.0
26.6
32
7
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
9.6
26.3
31
33
J02AC01
ATC
fluconazole; systemic
2.1
26.3
393
2365
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
26.3
142
548
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
25.9
79
214
H02AB04
ATC
methylprednisolone; systemic
2.5
25.7
195
890
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.7
25.3
59
130
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
25.1
116
410
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
39.9
25.0
31
8
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.3
24.7
42
69
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.8
24.6
46
83
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
28.3
24.6
33
12
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.7
24.3
46
84
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.8
23.7
30
35
L03AB05
ATC
interferon alfa-2b; parenteral
29.0
23.3
31
11
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
23.0
110
396
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
23.0
22
*
TPH00
NOMESCO Finland
Phlebotomy
21.2
22.7
33
16
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
22.4
140
580
H02AB06
ATC
prednisolone; systemic
1.9
22.4
544
3804
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
21.9
21
*
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
21.9
21
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
21.8
59
146
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
224.5
21.7
22
*
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
31.9
21.6
28
9
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
21.4
413
2671
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.8
20.5
32
48
JN4BD
NOMESCO Finland
Extensive body CT
2.4
20.1
149
668
A07AA02
ATC
nystatin; oral
3.0
20.1
94
334
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
19.9
19
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
19.9
19
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
19.9
19
*
170
Kela drug reimbursment
Bosutinib
+∞
19.9
19
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
19.8
269
1538
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
18.8
18
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
18.8
18
*
J05AX18
ATC
letermovir; oral
+∞
18.8
18
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
101.9
18.6
20
*
TAB00
NOMESCO Finland
Lumbar puncture
3.5
18.6
67
203
ZXD05
NOMESCO Finland
Urgent procedure
1.9
18.1
339
2146
306
Kela drug reimbursment
Erythropoietin and darbepoetin
19.7
16.9
25
13
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.7
16.7
54
152
1DB06, ,
NOMESCO Finland
+∞
16.7
16
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
16.7
16
*
D64.8
ICD-10 Finland
Other specified anaemias
4.8
16.7
38
82
WZC00
NOMESCO Finland
Treatment plan or consultation
1.8
16.6
392
2646
C03CA01
ATC
furosemide; systemic
1.7
15.9
408
2811
360
Kela drug reimbursment
Bosutinib
+∞
15.7
15
*
L01EA04
ATC
bosutinib; oral
+∞
15.7
15
*
ZX121
NOMESCO Finland
Central venous catheter
19.6
15.6
23
12
2AX04, ,
NOMESCO Finland
162.3
15.5
16
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
15.4
164
852
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
29.1
15.2
20
7
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
20.4
15.1
22
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
15.0
421
2961
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
25.4
14.7
20
8
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.2
14.7
25
41
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
14.6
14
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
81.3
14.6
16
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
15.6
14.4
23
15
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.1
14.4
39
97
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
14.3
260
1614
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.2
14.2
29
57
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.9
14.0
25
43
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.5
14.0
90
377
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
13.7
111
516
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
13.6
13
*
C421, 9877, 3
ICD-O-3
+∞
13.6
13
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
13.6
81
327
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
141.8
13.5
14
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
13.4
103
468
SPAT1088
SPAT
Blood transfusion
12.3
13.1
23
19
A01AB04
ATC
amphotericin B; local oral
2.8
13.1
69
261
B02AA02
ATC
tranexamic acid; systemic
2.1
12.9
139
722
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
22.9
12.9
18
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
12.9
147
781
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
12.5
12
*
1BC07, ,
NOMESCO Finland
+∞
12.5
12
*
J02AC05
ATC
isavuconazole; systemic
131.5
12.5
13
*
D11AH01
ATC
tacrolimus; topical
11.8
12.3
22
19
5BA08, ,
NOMESCO Finland
11.8
12.3
22
19
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
27.0
12.1
16
6
B01AB05
ATC
enoxaparin; parenteral
1.6
12.0
340
2369
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
13.6
12.0
20
15
L03AA13
ATC
pegfilgrastim; parenteral
2.7
11.8
62
235
6BA02, ,
NOMESCO Finland
30.4
11.7
15
5
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
65.7
11.6
13
*
A02BC02
ATC
pantoprazole; systemic
1.6
11.6
705
5865
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
5.8
11.5
21
37
C92
ICD-10 Finland
Myeloid leukaemia
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.9
11.5
25
52
A02BC01
ATC
omeprazole; systemic
1.7
11.5
293
1984
ZX108
NOMESCO Finland
Inhalation
9.0
11.3
23
26
174
Kela drug reimbursment
Ruxolitinib
35.4
11.3
14
*
J01FF01
ATC
clindamycin; systemic
1.7
11.3
283
1906
D75.2
ICD-10 Finland
Essential thrombocytosis
8.2
11.1
24
30
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
11.1
80
353
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
10.9
56
209
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
15.7
10.8
17
11
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.0
10.8
49
171
A04AA02
ATC
granisetron; systemic, transdermal
2.3
10.8
82
370
J01MA02
ATC
ciprofloxacin; systemic
1.6
10.8
418
3120
B74
ICPC
Malignant neoplasm blood other
28.3
10.7
14
5
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
10.7
222
1419
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
4.3
10.6
27
64
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
10.4
10
*
373
Kela drug reimbursment
Ponatinib
+∞
10.4
10
*
L01XE14
ATC
[U] bosutinib
+∞
10.4
10
*
1DB07, ,
NOMESCO Finland
+∞
10.4
10
*
A07AA09
ATC
vancomycin; oral
4.5
10.3
25
57
SPAT1074
SPAT
Venesection
9.7
10.3
20
21
L03AA04, ,
ATC
19.0
10.3
15
8
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.2
9.9
20
39
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
20.2
9.8
14
7
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
20.2
9.8
14
7
RS220, ,
NOMESCO Finland
5.0
9.8
21
43
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
55.5
9.7
11
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
55.5
9.7
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.0
9.6
42
144
L01XX35
ATC
anagrelide; oral
100.9
9.4
10
*
374
Kela drug reimbursment
Ruxolitinib
30.3
9.4
12
*
A98
ICPC
Health maint/preventive medicine
0.6
9.4
813
8913
B02.9
ICD-10 Finland
Zoster without complication
2.2
9.4
84
406
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
9.4
9
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
9.4
9
*
1529, ,
Kela drug reimbursment
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
8.1
9.4
20
25
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
9.2
307
2197
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
8.4
9.1
19
23
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
9.1
229
1535
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
15.7
9.0
14
9
Z2446
NOMESCO Finland
Social worker
2.2
9.0
77
366
K61.0
ICD-10 Finland
Anal abscess
4.3
8.9
23
55
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.9
8.9
42
150
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
24.2
8.9
12
5
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.9
8.9
19
39
ZXE00
NOMESCO Finland
One hour or less
1.5
8.7
377
2848
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
8.7
212
1406
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
8.7
69
318
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
8.5
496
3975
V03AC03
ATC
deferasirox; oral
90.8
8.4
9
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
90.8
8.4
9
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.8
8.4
20
30
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
8.3
8
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
8.3
8
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
8.3
8
*
L03AA10
ATC
lenograstim; parenteral
+∞
8.3
8
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
8.6
8.3
17
20
ZX100
NOMESCO Finland
Oral
3.9
8.3
24
63
N05CF01
ATC
zopiclone; oral
1.5
8.2
334
2485
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
8.2
112
630
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
8.2
126
737
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.0
354
2677
H02AB02
ATC
dexamethasone; systemic
1.8
7.9
123
722
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
11.9
7.6
13
11
C91.7
ICD-10 Finland
Other lymphoid leukaemia
25.2
7.6
10
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
6.2
7.6
19
31
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.4
7.6
26
77
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
7.5
113
656
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.8
7.4
36
131
WW500, ,
SPAT
80.6
7.4
8
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
13.5
7.4
12
9
TPX15
NOMESCO Finland
Removal of vascular injection port
11.0
7.3
13
12
L01EA05
ATC
ponatinib; oral
+∞
7.3
7
*
9872/3-C42.1
ICD-O-3
Acute myeloid leukemia, minimal differentiation of bone marrow
+∞
7.3
7
*
UJF32
NOMESCO Finland
Coloscopy
1.5
7.2
268
1948
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.7
7.2
22
60
L01EJ01
ATC
ruxolitinib; oral
30.2
7.2
9
*
L04AX03
ATC
methotrexate; systemic
1.9
7.0
94
527
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.0
6.9
19
48
N06DX01
ATC
memantine; oral
0.3
6.9
20
615
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
6.9
59
281
A12BA01
ATC
potassium chloride; oral
2.2
6.8
58
276
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
6.8
50
224
L03AB04
ATC
interferon alfa-2a; parenteral
16.8
6.7
10
6
G03DC03
ATC
lynestrenol; oral
3.9
6.7
19
49
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.5
6.6
16
25
RS221, ,
NOMESCO Finland
4.1
6.6
18
45
ZX114
NOMESCO Finland
Intramuscular
3.7
6.5
20
55
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
70.3
6.4
7
*
1BC01, ,
NOMESCO Finland
70.3
6.4
7
*
L01AA01
ATC
cyclophosphamide; systemic
7.5
6.4
14
19
B37.7
ICD-10 Finland
Candidal sepsis
14.4
6.4
10
7
D07AA02
ATC
hydrocortisone; topical
1.7
6.4
132
837
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
6.4
14
499
1XC02, ,
NOMESCO Finland
6.6
6.3
15
23
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.6
6.3
15
23
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.2
6.3
24
76
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
5.6
6.3
17
31
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
9.3
6.3
12
13
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
18.1
6.3
9
5
B01AC14
ATC
[U] anagrelide
+∞
6.3
6
*
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
6.3
6
*
L01EX13
ATC
gilteritinib; oral
+∞
6.3
6
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
6.3
6
*
D46
ICD-10 Finland
Myelodysplastic syndromes
+∞
6.3
6
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
26.8
6.2
8
*
N89.5
ICD-10 Finland
Stricture and atresia of vagina
26.8
6.2
8
*
L01XE18
ATC
[U] ruxolitinib
26.8
6.2
8
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
26.8
6.2
8
*
EBA10
NOMESCO Finland
Operative extraction of tooth
1.7
6.2
104
623
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
6.2
30
110
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
6.1
33
128
C07AB02
ATC
metoprolol; systemic
1.5
6.1
218
1570
H26.3
ICD-10 Finland
Drug-induced cataract
6.7
6.0
14
21
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
6.0
49
229
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.5
6.0
20
58
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
396
168
37.22
307.65
5.0
1.6
—
—
—
0
0
241
81
38.31
307.65
2.7
2.4
17.43
53.47
iu/ml
—
25
9
671
1182
13.94
307.65
20.0
4.2
296.25
250.37
u/l
2.77
661
1115
265
194
17.93
297.50
11.5
6.6
342.24
485.81
iu/ml
0.36
50
26
248
166
19.24
291.56
1.5
1.4
149.72
167.36
au/ml
0.84
66
49
509
964
9.30
288.50
7.1
2.7
64.80
68.89
e9/l
1.22
407
732
242
161
19.23
285.17
4.1
3.7
429.00
1898.88
u/ml
0.56
20
16
570
1243
8.83
283.14
7.4
2.8
1.84
1.79
%
0.40
554
1127
282
275
13.65
265.78
4.1
2.9
3.70
3.63
g/l
0.24
274
264
222
175
15.82
237.22
1.4
1.3
254.26
270.42
u/ml
0.20
137
96
382
721
7.75
209.86
3.2
3.0
9.72
11.13
g/l
5.93
369
662
202
7
357.32
206.32
1.1
1.0
—
—
—
0
0
518
1352
6.58
203.99
13.5
6.1
1.04
1.03
mmol/l
0.54
511
1244
239
271
11.12
200.55
4.0
1.7
—
—
—
0
0
322
577
7.60
183.76
1.6
1.7
1.13
1.37
g/l
0.96
309
528
223
266
10.37
179.41
3.7
1.6
—
—
—
0
0
107
27
44.01
178.03
1.3
1.0
—
—
—
0
0
175
149
13.89
177.08
10.4
4.0
1.29
1.36
%
0.07
166
138
221
271
10.06
173.88
1.6
1.7
—
—
—
0
0
176
182
11.41
156.30
4.3
1.7
—
—
—
0
0
506
1649
4.99
145.14
11.4
3.4
0.81
0.82
mmol/l
0.57
494
1548
258
480
6.80
139.38
1.8
2.0
1.43
1.56
g/l
1.10
229
430
618
2421
4.77
138.07
9.6
3.0
318.72
354.85
umol/l
10.54
598
2110
83
23
39.10
134.31
1.8
1.7
—
—
—
0
0
123
92
15.01
133.48
4.9
2.0
—
—
—
0
0
117
82
15.93
131.59
1.8
1.3
—
—
—
0
0
120
92
14.60
128.31
10.2
3.9
42.05
56.79
%
5.16
110
85
144
151
10.89
125.91
8.8
6.1
10.05
12.20
mg/l
5.11
138
138
123
102
13.52
125.49
4.9
1.9
—
—
—
0
0
112
0
+∞
119.07
1.0
0.0
—
—
—
0
0
101
0
+∞
107.15
16.5
0.0
—
—
—
0
0
158
237
7.67
103.26
2.1
1.5
—
—
—
0
0
97
78
13.60
100.44
1.1
1.1
—
—
—
0
0
105
96
12.04
100.34
4.1
2.8
—
—
—
0
0
308
881
4.53
99.37
2.5
3.1
65.48
66.55
g/l
1.70
300
813
426
1551
3.94
98.26
4.6
2.1
28.99
29.62
s
1.39
417
1503
95
86
12.04
91.23
5.0
1.6
—
—
—
0
0
95
86
12.04
91.23
5.0
1.6
—
—
—
0
0
95
86
12.04
91.23
5.0
1.6
—
—
—
0
0
110
133
9.12
85.78
2.3
1.6
—
—
—
0
0
131
200
7.34
83.78
1.9
1.5
—
—
—
0
0
260
739
4.35
83.30
3.4
1.7
—
—
—
0
0
129
195
7.40
83.24
1.3
1.2
148.14
30.95
u/l
4.19
117
171
64
34
19.98
81.97
6.4
1.9
—
—
—
0
0
64
34
19.98
81.97
6.4
1.9
—
—
—
0
0
67
40
17.82
81.27
6.4
2.1
677.19
577.33
e6/l
0.37
62
33
70
46
16.23
80.90
6.1
1.7
—
—
—
0
0
70
46
16.23
80.90
6.1
1.7
—
—
—
0
0
70
46
16.23
80.90
6.1
1.7
—
—
—
0
0
70
46
16.23
80.90
6.1
1.7
—
—
—
0
0
64
35
19.41
80.89
6.4
1.8
—
—
—
0
0
73
52
15.01
80.80
6.9
3.8
1.64
1.02
%
1.35
73
52
429
1758
3.43
79.54
4.7
1.9
—
—
—
0
0
106
137
8.49
78.21
2.1
1.7
—
—
—
0
0
71
55
13.77
74.87
1.5
1.8
—
—
—
0
0
71
55
13.77
74.87
1.5
1.8
—
—
—
0
0
84
92
9.84
70.42
1.7
1.7
—
—
—
0
0
56
34
17.34
67.22
1.6
3.2
9104.57
63487.57
u/ml
—
7
7
98
139
7.67
66.64
5.0
2.2
33.52
32.39
pg
1.43
98
139
397
1701
3.14
66.12
1.6
1.5
2.26
2.56
g/l
2.61
343
1036
125
237
5.85
64.19
1.5
2.1
23.47
12.48
mg/l
1.41
106
218
48
24
20.91
62.92
1.8
1.4
—
—
—
0
0
267
932
3.50
61.97
9.3
7.6
8.30
10.48
mmol/l
5.82
260
887
146
330
4.98
61.48
2.3
1.3
—
—
—
0
0
65
60
11.48
61.32
2.3
2.9
37.11
38.78
%
0.18
28
31
333
1347
3.15
60.46
3.4
1.8
—
—
—
0
0
796
5156
3.24
60.21
46.6
9.7
3.59
4.19
e9/l
1.44
746
4507
112
206
5.97
59.27
2.2
1.5
—
—
—
0
0
424
2003
2.87
57.70
3.2
1.7
3.11
1.38
mg/l
4.12
373
1581
768
4941
3.06
57.45
27.7
6.9
11.49
11.88
umol/l
0.47
750
4718
100
173
6.28
56.28
2.2
1.5
—
—
—
0
0
308
1274
3.01
52.84
3.5
1.9
—
—
—
0
0
736
4862
2.71
47.99
21.1
7.6
1.21
1.21
mmol/l
0.45
646
4179
54
55
10.30
47.50
1.5
1.3
—
—
—
0
0
268
1088
2.96
46.92
13.3
2.9
7.51
8.54
umol/l
0.40
258
975
155
452
3.85
46.32
2.9
1.9
5.41
2.11
ug/l
0.62
149
401
140
382
4.07
45.92
3.4
3.0
—
—
—
0
0
48
44
11.38
45.35
2.7
1.3
—
—
—
0
0
48
44
11.38
45.35
2.7
1.3
—
—
—
0
0
675
4377
2.52
44.04
18.2
6.9
1.20
1.21
mmol/l
1.12
650
4023
45
40
11.71
43.35
1.2
1.4
—
—
—
0
0
660
4287
2.45
42.09
14.7
5.3
33.95
35.18
g/l
6.11
644
4020
53
62
8.95
42.03
2.5
1.4
—
—
—
0
0
70
115
6.45
41.29
1.4
2.0
—
2512.00
—
0
5
52
62
8.77
40.62
2.6
1.4
—
—
—
0
0
341
1700
2.49
38.76
2.8
2.7
15.51
12.54
umol/l
8.38
331
1588
302
1473
2.47
35.54
2.8
2.7
29.80
22.45
%
9.10
288
1385
318
1588
2.44
35.54
2.7
2.7
2.12
2.28
g/l
6.16
305
1480
41
43
9.88
35.23
2.4
2.2
—
—
—
0
0
118
357
3.60
33.05
3.1
4.0
41.50
67.64
mg/l
0.81
101
308
403
2288
2.23
32.90
13.5
2.5
—
—
—
0
0
63
117
5.66
32.74
4.3
1.5
—
—
—
0
0
63
119
5.57
32.15
4.3
1.5
—
—
—
0
0
63
119
5.57
32.15
4.3
1.5
—
—
—
0
0
116
356
3.54
31.76
3.2
4.0
26.99
54.56
mg/l
1.79
99
310
110
328
3.63
31.45
2.6
3.8
4.21
2.60
ratio
0.36
74
197
406
2347
2.19
31.36
10.7
4.3
84.17
86.98
%
1.45
397
2304
41
51
8.32
30.90
1.4
6.7
—
33.67
—
0
12
618
4228
2.12
30.40
13.6
2.9
—
—
estimate
—
0
0
113
372
3.28
27.61
6.3
1.9
—
—
—
0
0
161
658
2.71
26.70
3.2
1.7
—
—
—
0
0
56
114
5.13
26.29
4.6
1.5
—
—
—
0
0
56
114
5.13
26.29
4.6
1.5
—
—
—
0
0
56
115
5.09
26.03
4.6
1.5
—
—
—
0
0
110
375
3.16
25.32
1.8
2.7
9.58
10.99
g/l
2.43
105
338
583
4081
1.96
24.84
4.6
3.1
475.48
141.93
ug/l
9.55
564
3773
90
279
3.43
24.14
3.4
1.3
—
—
—
0
0
102
347
3.15
23.53
3.0
1.8
—
—
—
0
0
29
11
27.06
21.42
1.4
1.7
—
—
—
0
0
712
5514
1.90
20.44
12.4
5.5
6.74
6.74
mmol/l
0.03
697
5268
398
2614
1.84
19.11
2.7
2.3
2.90
2.98
mg/l
0.26
351
2241
30
46
6.68
18.82
2.8
2.5
1263.40
960.04
u/ml
0.49
30
46
438
2978
1.81
18.65
3.8
2.7
51.19
88.18
u/l
0.77
419
2759
124
532
2.51
18.37
1.6
1.5
—
—
—
0
0
440
3021
1.79
17.94
6.5
3.3
33.85
33.56
u/l
0.04
425
2861
30
23
13.39
17.51
1.8
1.3
—
—
—
0
0
72
238
3.17
17.38
1.9
1.5
—
—
—
0
0
608
4635
1.74
16.74
15.8
17.4
1.25
1.30
inr
1.81
551
3901
286
1776
1.84
15.93
1.9
1.8
1230.92
1175.85
nmol/l
0.45
253
1338
144
706
2.20
15.65
6.0
3.8
5.04
5.15
kpa
1.03
139
678
38
87
4.49
15.53
2.4
1.6
—
—
—
0
0
535
3990
1.69
15.48
40.3
11.9
0.06
0.00
e9/l
0.95
460
3277
73
263
2.91
15.19
1.4
1.3
—
—
—
0
0
92
378
2.57
14.87
1.6
2.9
0.27
1.31
g/l
3.15
83
335
444
3192
1.68
14.45
3.6
3.4
1417.14
1602.79
ng/l
0.36
416
2775
59
194
3.16
14.38
1.2
1.3
219.71
234.65
miu/ml
0.08
15
87
412
2912
1.68
14.26
2.1
1.8
19.01
20.14
nmol/l
0.88
381
2462
126
609
2.21
14.14
5.7
3.8
0.90
2.01
mmol/l
3.07
100
447
23
16
14.67
14.09
6.2
2.3
2.00
2.31
%
0.18
23
16
44
122
3.72
13.95
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
85
348
2.57
13.83
3.1
2.8
0.31
0.37
iu/ml
0.82
45
185
61
213
2.98
13.43
1.4
1.6
—
—
—
0
0
51
160
3.30
13.43
2.7
2.2
22463.57
5637.65
u/l
0.62
15
55
78
321
2.54
12.56
1.5
2.7
0.00
0.00
g/l
-0.00
73
282
808
6910
1.73
12.45
35.8
8.5
82.62
80.77
u/l
0.56
794
6534
57
202
2.93
12.23
2.9
1.3
44.24
808.99
e6/l
0.78
45
162
288
1918
1.69
12.09
5.3
4.3
112.87
384.30
ng/l
3.83
243
1583
56
200
2.90
11.86
2.9
1.3
8.02
58.41
e6/l
0.96
41
154
15
5
30.40
11.66
1.7
6.4
—
—
—
0
0
47
154
3.15
11.55
1.2
1.1
—
1.87
—
0
6
544
4279
1.56
11.26
2.5
2.2
92.23
94.68
pmol/l
0.57
385
2260
27
65
4.24
10.40
2.5
1.5
—
—
—
0
0
402
2993
1.56
10.38
3.9
2.2
146.16
239.20
u/l
2.39
390
2829
751
8419
0.62
10.27
6.2
6.1
2.46
2.61
mmol/l
4.87
715
7731
421
3187
1.54
9.98
5.0
3.6
229.44
84.57
e6/l
0.34
339
2494
434
3309
1.53
9.94
5.9
3.5
2.31
2.35
mmol/l
6.86
404
2997
26
63
4.21
9.93
2.6
1.5
—
—
—
0
0
28
73
3.91
9.72
2.5
1.5
—
—
—
0
0
56
224
2.58
9.59
2.5
1.3
500.14
544.01
mg/l
0.37
56
214
9
0
+∞
9.39
5.4
0.0
—
—
—
0
0
25
62
4.11
9.28
1.3
1.2
—
—
—
0
0
142
840
1.80
8.87
3.9
3.2
217.39
230.49
ng/l
0.19
135
777
154
945
1.74
8.47
2.7
2.4
0.21
0.21
g/l
0.20
139
881
8
0
+∞
8.34
11.0
0.0
—
—
—
0
0
15
14
10.85
8.30
1.3
1.0
—
—
—
0
0
25
68
3.74
8.21
3.3
1.7
—
—
—
0
0
740
8219
0.66
8.00
5.6
5.2
1.29
1.44
mmol/l
18.91
699
7536
57
252
2.33
7.92
2.1
2.1
116.02
128.80
g/l
2.21
44
199
73
358
2.12
7.90
3.7
2.9
24.32
24.80
mmol/l
0.65
73
352
357
2741
1.46
7.34
4.9
3.4
0.56
0.45
e6/l
0.30
278
2058
7
0
+∞
7.30
3.0
0.0
8.23
—
ng/l
—
7
0
61
288
2.19
7.27
1.6
1.6
—
—
—
0
0
846
9104
0.64
7.23
85.2
27.4
115.27
134.39
g/l
112.63
837
8990
846
9102
0.64
7.18
84.7
27.2
3.83
4.46
e12/l
94.48
831
8883
846
9102
0.64
7.18
85.6
27.8
34.83
40.11
%
96.09
837
8980
846
9101
0.64
7.16
84.9
27.2
189.97
244.52
e9/l
40.46
833
8912
682
5908
1.44
7.14
6.3
5.1
141.84
2148.02
e6/l
2.08
19
106
186
1251
1.59
7.13
9.1
8.3
4.89
5.11
kpa
2.09
179
1206
846
9099
0.64
7.11
84.6
27.1
93.74
91.43
fl
26.16
838
8985
186
1252
1.59
7.10
9.1
8.2
11.71
11.86
kpa
0.16
178
1209
49
215
2.34
6.95
2.5
1.4
12.51
7.96
u/l
0.92
43
169
226
1597
1.53
6.95
4.7
3.3
2.39
2.14
e6/l
0.15
121
829
299
2240
1.47
6.91
3.6
2.8
4.86
5.08
e6/l
0.11
283
2057
47
203
2.38
6.91
1.5
1.3
—
—
—
0
0
47
203
2.38
6.91
1.5
1.3
—
—
—
0
0
169
1123
1.60
6.80
9.9
8.6
95.68
95.36
%
0.24
163
1090
181
1236
1.56
6.47
9.6
8.3
1.21
1.03
mmol/l
0.23
146
1014
755
8263
0.69
6.29
5.8
5.3
4.23
4.51
mmol/l
10.34
722
7631
18
47
3.88
6.28
3.8
1.2
28.22
6.51
ug/l
1.16
18
41
6
0
+∞
6.25
1.2
0.0
—
—
—
0
0
71
383
1.92
5.95
1.7
2.0
37.95
39.02
u/l
0.18
63
333
17
36
4.78
5.62
1.8
1.3
—
—
—
0
0
734
8030
0.72
5.59
6.6
6.9
39.12
39.77
mmol/mol
1.39
697
7450
13
21
6.25
5.39
3.4
1.0
—
—
—
0
0
153
1047
1.54
5.38
5.4
3.9
1.78
2.01
mmol/l
0.28
130
887
55
282
2.00
5.35
1.5
1.5
0.18
25.11
iu/ml
—
10
48
23
79
2.95
5.32
1.6
1.4
13.48
14.04
u/l
0.12
23
73
11
16
6.93
4.96
1.1
1.4
—
—
—
0
0
445
3734
1.33
4.87
4.1
4.2
61.08
82.40
ng/l
0.25
359
2821
32
138
2.36
4.79
1.5
1.4
1951.85
1498.44
e6/l
0.44
27
91
225
1705
1.41
4.68
4.7
3.1
1.45
1.00
e6/l
0.67
126
939
728
6582
1.35
4.62
6.6
4.4
19.26
12.98
mm/h
12.85
693
6113
67
389
1.77
4.50
2.4
2.2
137.59
489.55
ug/l
1.89
61
371
842
8936
0.71
4.49
67.9
23.8
86.32
81.74
umol/l
2.04
831
8825
26
106
2.49
4.40
5.1
2.0
0.70
0.56
mmol/l
0.07
26
101
52
284
1.87
4.26
1.5
1.5
235.07
271.93
ug/g
0.64
27
171
294
3592
0.75
4.24
2.4
2.0
1.67
1.34
mmol/l
3.00
266
2988
834
8850
0.72
4.24
43.1
12.7
26.83
26.03
u/l
0.81
815
8583
128
888
1.50
4.23
2.6
2.4
54.69
90.48
u/l
0.26
113
750
15
46
3.29
4.20
1.3
1.6
3.09
3.28
ug/l
—
9
38
759
8162
0.75
4.14
6.7
5.4
6.07
6.02
mmol/l
0.53
708
7401
26
111
2.38
4.02
1.1
1.4
215.90
308.61
pmol/l
1.45
20
94
46
247
1.90
3.99
2.3
1.4
23.58
24.04
iu/l
0.04
39
204
16
53
3.05
3.97
1.1
1.0
—
—
—
0
0
33
157
2.14
3.97
1.2
1.3
—
—
—
0
0
75
468
1.65
3.92
3.6
3.5
4.49
4.43
pmol/l
0.22
68
408
27
119
2.30
3.90
1.6
1.4
78873.50
35357.13
e6/l
0.35
18
62
12
29
4.17
3.71
1.2
1.0
—
—
—
0
0
8
12
6.71
3.67
1.0
1.2
—
—
—
0
0
254
2043
1.32
3.54
1.6
1.8
58491040.52
15818286.84
pmol/l
0.33
212
1669
33
166
2.02
3.47
1.6
1.5
35.43
31.37
g/l
1.63
33
151
83
552
1.55
3.36
5.4
4.1
48.58
47.47
%
0.15
83
542
535
4754
1.26
3.31
3.8
2.8
—
—
—
0
0
535
4755
1.25
3.30
4.5
4.2
10.16
1.57
estimate
0.39
121
1034
12
33
3.67
3.29
1.3
1.1
—
—
—
0
0
45
258
1.78
3.22
4.4
3.6
4.04
2.01
index
0.63
31
135
538
4794
1.25
3.21
4.6
4.2
0.01
0.31
estimate
0.50
111
978
529
4705
1.25
3.21
4.5
4.2
0.00
0.00
estimate
0.50
119
1013
10
24
4.20
3.20
1.0
1.2
—
—
—
0
0
25
118
2.15
3.12
4.1
4.0
—
—
—
0
0
738
7876
0.79
3.03
5.7
4.4
1.52
1.28
mmol/l
4.61
700
7164
13
45
2.91
3.03
2.2
1.6
53.69
65.94
mg/l
0.35
13
35
24
115
2.11
2.90
1.3
1.2
1.38
3.11
u/ml
—
8
36
6
9
6.70
2.87
1.0
1.3
—
—
—
0
0
12
38
3.18
2.85
3.8
1.3
—
—
—
0
0
10
28
3.60
2.78
1.0
1.1
—
—
—
0
0
20
92
2.20
2.68
1.3
1.3
11.55
13.52
u/l
0.29
20
82
735
7811
0.80
2.64
5.9
5.3
2.00
1.96
mu/l
0.33
691
7141
13
49
2.67
2.63
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
49
2.67
2.63
1.3
1.1
—
—
—
0
0
20
93
2.17
2.62
1.5
2.5
734.15
1003.89
mg
0.32
20
93
14
56
2.52
2.53
1.4
1.1
27.14
43.37
mg/l
1.29
14
44
769
8118
0.80
2.49
47.6
17.6
76.23
77.73
ml/min/173m2
1.07
738
7578
311
2672
1.23
2.44
4.5
4.2
0.00
0.01
estimate
1.15
106
931
167
2061
0.77
2.39
3.0
3.3
0.69
0.79
ug/l
1.11
107
1379
46
704
0.64
2.36
2.0
2.1
3.93
3.51
ratio
0.78
40
573
71
502
1.44
2.22
4.4
3.6
24.23
25.29
mmol/l
1.72
71
483
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
10
35
2.87
2.21
1.1
2.1
2.08
1.74
umol/l
—
10
29
21
108
1.96
2.16
1.0
1.1
122.33
115.77
%
0.40
21
101
14
61
2.31
2.15
1.0
1.2
—
—
—
0
0
13
55
2.38
2.12
1.4
1.1
236.15
262.74
mg/l
0.26
13
47
22
116
1.92
2.12
1.3
1.2
3.00
5.39
u/ml
—
10
57
112
863
1.33
2.11
2.3
2.5
4.37
7.46
ug/l
2.61
99
771
20
103
1.96
2.06
1.6
1.4
—
—
—
0
0
45
295
1.55
2.03
6.2
3.7
3.77
3.93
mmol/l
1.32
45
290
838
8718
0.81
2.01
63.4
22.1
3.98
3.99
mmol/l
0.50
828
8534
91
687
1.36
1.97
12.7
10.0
1.45
1.33
%
0.66
91
681
36
227
1.61
1.92
1.2
1.2
—
—
—
0
0
40
261
1.55
1.86
1.6
1.7
—
—
—
0
0
11
46
2.41
1.85
1.9
1.6
1.50
3.12
u/field
—
6
34
839
8712
0.82
1.85
57.3
21.8
139.21
139.63
mmol/l
5.47
827
8539
44
295
1.51
1.82
1.5
1.6
1.20
1.17
g/l
0.27
44
278
98
758
1.32
1.82
4.6
4.2
84.87
93.94
ng/l
0.51
92
668
33
509
0.64
1.80
1.8
1.8
3.38
3.45
mmol/l
0.14
26
380
243
2795
0.83
1.79
4.1
4.8
21.16
21.62
%
0.19
117
1409
13
60
2.18
1.78
1.0
1.2
—
—
—
0
0
23
383
0.59
1.73
1.7
1.6
0.42
0.33
mg/l
0.31
13
176
52
366
1.44
1.71
1.4
1.3
—
—
—
0
0
294
3314
0.84
1.71
3.4
3.4
7.29
7.49
mmol/l
0.37
258
2780
131
1064
1.26
1.70
3.8
4.3
12.56
23.14
ug/l
0.43
100
883
441
4026
1.16
1.65
3.1
2.5
76.48
77.93
nmol/l
0.48
417
3584
7
25
2.81
1.65
1.0
1.1
—
—
—
0
0
11
49
2.26
1.64
1.4
1.4
61.55
18.36
umol/l
2.21
11
43
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
34
223
1.54
1.58
1.3
1.3
—
—
—
0
0
37
248
1.51
1.57
1.2
1.2
—
—
—
0
0
130
1066
1.25
1.56
2.0
2.3
126.03
132.93
ug/g
0.12
102
844
37
249
1.50
1.54
1.2
1.2
—
—
—
0
0
289
3233
0.85
1.51
4.2
4.2
12.33
9.07
mg/mmol
0.52
196
2030
13
65
2.01
1.49
1.2
1.2
—
—
—
0
0
53
716
0.73
1.48
1.6
1.5
—
—
—
0
0
19
109
1.76
1.47
1.0
1.1
—
—
—
0
0
32
212
1.53
1.44
2.8
3.6
768.27
1478.16
u/ml
0.22
27
202
5
16
3.13
1.44
4.0
7.6
13.80
7.69
%
—
5
16
38
263
1.46
1.40
1.2
1.2
—
16.73
—
0
12
11
53
2.09
1.38
1.2
1.0
—
—
—
0
0
13
67
1.95
1.38
1.2
1.1
—
—
—
0
0
29
190
1.54
1.38
2.9
4.0
37.85
26.51
mg/l
1.18
22
138
20
119
1.69
1.38
1.5
1.5
6.44
6.22
mmol/l
0.19
20
113
13
235
0.55
1.36
1.2
1.2
0.86
0.91
g/l
0.33
13
235
12
222
0.54
1.36
1.2
1.1
1.62
1.52
g/l
0.58
12
222
13
68
1.92
1.33
1.2
1.1
—
—
—
0
0
13
68
1.92
1.33
1.2
1.1
—
—
—
0
0
284
2551
1.16
1.28
3.9
3.6
0.00
0.05
estimate
0.83
91
797
8
35
2.30
1.27
1.0
1.1
97.73
268.59
iu/ml
—
8
35
6
25
2.41
1.24
1.2
1.1
—
—
—
0
0
6
25
2.41
1.24
1.2
1.1
—
—
—
0
0
6
25
2.41
1.24
1.0
1.1
—
—
—
0
0
6
26
2.31
1.19
1.2
1.2
—
—
—
0
0
6
26
2.31
1.19
1.0
1.2
—
—
—
0
0
29
198
1.48
1.18
1.1
1.2
—
49.59
—
0
20
388
3580
1.13
1.17
4.3
4.2
0.00
0.04
estimate
3.49
103
843
8
39
2.06
1.15
1.4
1.7
40.31
39.95
g/l
—
8
39
5
20
2.51
1.15
7.6
2.2
85.00
120.48
ng/l
—
5
13
14
80
1.76
1.13
1.1
1.2
—
—
—
0
0
8
41
1.96
1.09
1.1
1.2
—
—
—
0
0
36
263
1.38
1.05
1.4
1.3
—
—
—
0
0
13
75
1.74
1.03
1.2
1.1
—
—
—
0
0
9
47
1.92
1.02
2.6
4.1
—
—
—
0
0
32
232
1.39
0.98
5.1
3.4
7.48
7.69
mmol/l
0.19
32
227
171
1927
0.87
0.97
1.3
1.3
1.43
1.62
u/ml
0.12
43
522
0
30
0.00
0.97
0.0
1.8
—
0.65
—
0
6
53
668
0.78
0.97
2.0
2.1
—
—
—
0
0
222
1999
1.14
0.97
3.5
3.1
2.45
2.46
mmol/l
0.35
208
1808
48
611
0.78
0.95
1.9
2.0
—
—
—
0
0
8
143
0.56
0.93
1.1
1.1
1.49
1.53
g/l
—
8
131
99
841
1.20
0.91
3.6
2.4
13.61
13.32
nmol/l
0.14
91
755
14
86
1.64
0.91
1.0
1.1
85.43
98.15
%
0.83
14
80
324
3490
0.90
0.90
4.7
5.8
3.57
3.02
ug/l
0.12
294
3123
116
1003
1.18
0.88
5.6
3.7
—
—
—
0
0
162
1443
1.15
0.84
1.3
1.3
1.46
13.57
u/ml
7.76
54
520
10
165
0.60
0.82
1.4
1.6
969.36
948.39
mu/l
—
10
140
75
630
1.21
0.80
13.0
10.3
23.92
24.45
mmol/l
0.72
70
620
13
82
1.59
0.78
1.9
2.0
0.83
1.70
u/field
—
6
44
46
369
1.26
0.75
1.5
1.9
6.42
7.78
iu/ml
0.19
12
93
20
142
1.42
0.72
1.2
1.1
—
—
—
0
0
29
220
1.33
0.72
1.5
1.3
—
—
—
0
0
7
41
1.71
0.70
3.0
1.7
30.86
50.69
ug/l
—
7
41
586
5638
1.09
0.70
4.4
3.5
68.87
52.85
u/l
2.41
556
5271
7
43
1.63
0.67
1.7
1.1
291.14
462.76
u/l
—
7
38
12
78
1.54
0.65
1.3
1.1
112.50
100.45
pmol/l
0.47
12
78
125
1118
1.13
0.64
3.9
5.0
29.37
32.30
%
2.38
101
717
13
87
1.50
0.63
1.5
2.7
7.88
8.31
mmol/l
0.32
13
87
13
87
1.50
0.63
1.0
1.4
—
—
—
0
0
32
252
1.28
0.63
2.9
3.4
0.78
0.81
nmol/l
0.18
22
209
15
104
1.45
0.62
1.5
1.4
18.37
27.25
ng/l
1.26
15
104
231
2143
1.10
0.62
4.3
4.4
1.02
1.02
kg/l
0.03
177
1453
16
113
1.42
0.61
2.6
2.8
73.60
22.76
mg/l
—
5
46
8
50
1.60
0.61
2.3
2.5
—
—
—
0
0
0
20
0.00
0.60
0.0
2.5
—
—
—
0
0
63
538
1.18
0.60
1.7
1.2
391.66
266.85
u/ml
0.30
53
494
11
72
1.53
0.59
2.5
2.3
830.20
622.45
ml
—
5
44
139
1259
1.12
0.59
1.5
1.5
—
—
—
0
0
31
387
0.79
0.59
1.1
1.1
—
—
—
0
0
6
35
1.72
0.57
1.8
2.2
72.17
46.42
umol/l
—
6
29
6
37
1.63
0.55
1.0
1.0
1402.83
1571.78
miu/ml
—
6
37
6
38
1.58
0.54
13.0
3.3
11.55
9.96
kpa
—
6
38
6
38
1.58
0.54
13.0
3.3
5.09
4.88
kpa
—
6
38
106
960
1.12
0.47
1.6
1.5
—
—
—
0
0
83
747
1.12
0.42
4.9
2.9
62.34
63.69
ml/min/173m2
0.11
47
331
6
92
0.65
0.42
1.0
1.3
—
—
—
0
0
6
95
0.63
0.42
1.3
1.6
78.95
64.63
ug/l
—
6
79
10
70
1.43
0.41
1.0
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
91.20
106.50
%
—
5
26
16
205
0.78
0.40
1.6
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
12
89
1.35
0.38
1.0
1.1
—
—
—
0
0
5
79
0.63
0.35
1.2
1.7
—
—
—
0
0
18
150
1.20
0.26
1.2
1.6
—
—
—
0
0
6
83
0.72
0.24
1.2
1.0
326.17
279.76
mg/l
—
6
74
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
161
1545
1.05
0.21
1.3
1.3
24.08
33.01
iu/ml
0.79
55
482
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
91
962
0.94
0.20
1.6
1.8
1.59
1.52
%
0.32
77
828
14
164
0.85
0.18
1.5
1.4
—
—
—
0
0
7
58
1.21
0.18
1.3
1.6
78.43
83.78
umol/l
—
7
58
111
1060
1.05
0.18
11.5
8.0
—
—
—
0
0
5
67
0.75
0.17
2.4
1.4
—
—
—
0
0
28
308
0.91
0.16
2.1
2.3
—
—
—
0
0
26
287
0.90
0.16
2.8
2.0
42.65
41.23
nmol/l
0.07
26
273
28
256
1.10
0.14
1.4
1.5
14630.26
16661.77
e6/l
0.14
19
180
10
87
1.15
0.09
1.3
1.1
—
81.83
—
0
6
23
213
1.08
0.09
1.5
1.8
2.25
32.06
iu/l
—
6
83
841
8447
0.98
0.09
62.9
18.0
26.96
26.35
mg/l
0.22
798
7081
6
55
1.09
0.09
2.2
1.4
—
—
—
0
0
6
58
1.03
0.08
1.3
1.8
65.83
109.50
ng/l
—
6
58
5
60
0.83
0.08
2.0
2.5
—
—
—
0
0
5
63
0.79
0.08
1.4
1.5
53.37
53.02
ug/l
—
5
63
54
519
1.04
0.08
1.1
1.2
45.05
116.82
u/ml
2.93
19
196
13
117
1.11
0.08
1.4
1.3
0.48
0.63
nmol/l
1.62
13
110
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
15
162
0.92
0.06
1.5
1.5
80.27
344.74
pmol/l
1.78
15
157
651
6535
0.99
0.04
4.6
4.2
14.96
14.94
pmol/l
0.08
613
5924
24
239
1.00
0.00
2.5
2.4
411.25
97.36
ug/min
0.43
12
146
26
261
1.00
0.00
2.0
2.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
384.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
2.0
2.2
14.03
13.17
%
—
6
66
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
50
1.00
-0.00
2.2
1.4
152.54
178.17
pmol/l
—
5
50
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MYELOID_LEUKAEMIA – Myeloid leukaemia
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).